#LongTermVision

Formulated the long-term vision 'YUASA vision 370' looking toward the 370th anniversary in 2036, and the five-year medium-term management plan 'Reborn 2031' starting from April 2026. Targets include ordinary income of over 30 billion yen, ROIC over 10%, and overseas sales exceeding 100 billion yen for the fiscal year ending March 2036.

Formulated the long-term vision 'BLOOMING VISION 2035' toward 2035 and the 4th Medium-term Management Plan 2028 starting fiscal 2026. Targets fiscal 2035 sales of 300 billion yen, operating income of 23 billion yen, and ROE above 8%.

Asuka Pharmaceutical Holdings has formulated the long-term vision "ASKA VISION 2035" looking ahead to 2035 and the "Medium-Term Management Plan 2028" for the three years starting fiscal 2026, targeting net sales of 85 billion yen and an operating income margin of 10%.

Fukuda Corporation has formulated the long-term vision "FUKUDA VISION 2035" targeting the fiscal years from December 2026 to December 2035, and the Medium-Term Management Plan 2030 for the five years from December 2026 to December 2030. The company aims for net sales of 220 billion yen, an operating profit margin of 6.5%, and ROE of 8.5%.

Seiko Epson has formulated the long-term vision 'ENGINEERED FUTURE 2035' and Medium-term Management Plan Phase 1 (FY2026–2028), planning approximately 280 billion yen in growth investments over three years.

Upward revision of the operating profit margin target for the 2027 Medium-Term Management Plan from 11.5% to 15.0%, and operating profit from 92 billion yen to 120 billion yen. The 2030 operating profit margin target is also raised from 12.5% to 15.0%.